Literature DB >> 10049978

Tyrosinemia type 1 should be suspected in infants with severe coagulopathy even in the absence of other signs of liver failure.

J M Croffie1, S K Gupta, S K Chong, J F Fitzgerald.   

Abstract

Tyrosinemia type l is an inherited metabolic disorder attributable to deficiency of fumarylacetoacetate hydrolase, a terminal enzyme in the degradation pathway of tyrosine. Affected individuals may present with any of a number of signs and symptoms, including failure to thrive, fever, vomiting, diarrhea, hepatomegaly, ascites, jaundice, renal Fanconi syndrome, or conditions such as rickets and hepatocellular carcinoma.1 If untreated, the patient may die of acute liver failure before the second year of life, or from chronic liver failure or hepatocellular carcinoma before the end of the second decade of life.2 Although overt liver failure with coagulopathy may be part of the presentation of tyrosinemia, a significant coagulopathy in the absence of overt signs of liver disease has not been emphasized as a clue to the diagnosis of this condition. We report two tyrosinemic infants who presented with severe coagulopathies and no other signs of liver failure to stress this diagnostic point.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10049978     DOI: 10.1542/peds.103.3.675

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

Review 1.  Recent advances in pediatric liver transplantation.

Authors:  Debora Kogan-Liberman; Sukru Emre; Benjamin L Shneider
Journal:  Curr Gastroenterol Rep       Date:  2002-02

2.  Hereditary tyrosinemia type 1 from a single center in Egypt: clinical study of 22 cases.

Authors:  Hanaa El-Karaksy; Mona Fahmy; Mona El-Raziky; Nehal El-Koofy; Rokaya El-Sayed; Mohamed S Rashed; Hasan El-Kiki; Ahmad El-Hennawy; Nabil Mohsen
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

3.  An infant with prolonged circumcision bleeding and unexplained coagulopathy.

Authors:  Ali Bay; Ozlem Karaoglu; Ercan Sivasli; Göksel Leblebisatan; Mehmet Keskin
Journal:  Indian J Hematol Blood Transfus       Date:  2011-09-21       Impact factor: 0.900

4.  Persistent coagulopathy during Escherichia coli sepsis in a previously healthy infant revealed undiagnosed tyrosinaemia type 1.

Authors:  H Georgouli; K H Schulpis; H Michelakaki; M Kaltsa; T Sdogou; L Kossiva
Journal:  BMJ Case Rep       Date:  2010-12-29

5.  Tyrosinemia Typel: A case report.

Authors:  Mohmood M Rashad; Carmen Nassar
Journal:  Sudan J Paediatr       Date:  2011

6.  Nitisinone in the treatment of hereditary tyrosinaemia type 1.

Authors:  Patrick J McKiernan
Journal:  Drugs       Date:  2006       Impact factor: 9.546

7.  Tyrosinemia type 1: a rare and forgotten cause of reversible hypertrophic cardiomyopathy in infancy.

Authors:  Sarar Mohamed; Mohammed A Kambal; Nasir A Al Jurayyan; Abdulrahman Al-Nemri; Amir Babiker; Rana Hasanato; Abdullah S Al-Jarallah
Journal:  BMC Res Notes       Date:  2013-09-09

8.  Coagulopathy in Zellweger spectrum disorders: a role for vitamin K.

Authors:  Sara Zeynelabidin; Femke C C Klouwer; Joost C M Meijers; Monique H Suijker; Marc Engelen; Bwee Tien Poll-The; C Heleen van Ommen
Journal:  J Inherit Metab Dis       Date:  2017-11-14       Impact factor: 4.982

9.  Revisiting hereditary tyrosinemia Type 1-spectrum of radiological findings.

Authors:  Sana Shaikh; Asma Qureshi; Syed Mohammad Faiq
Journal:  BJR Case Rep       Date:  2018-11-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.